used in common Chinese, Ayurvedic, and Thai medicine. Conolidine could represent the beginning of a brand new period of chronic pain management. Now it is getting investigated for its results to the atypical chemokine receptor (ACK3). Within a rat design, it was uncovered that a competitor molecule binding to ACKR3 resulted in inhibition of ACKR3�